[HTML][HTML] Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

NA Aziz, VM Corman, AKC Echterhoff… - Nature …, 2021 - nature.com
To estimate the seroprevalence and temporal course of SARS-CoV-2 neutralizing
antibodies, we embedded a multi-tiered seroprevalence survey within an ongoing …

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany

NA Aziz, VM Corman, AKC Echterhoff, A Richter… - medRxiv, 2020 - medrxiv.org
Background Accurate estimates of SARS-CoV-2 seroprevalence are crucial for the
implementation of effective public health measures, but are currently largely lacking in …

[PDF][PDF] Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany

NA Aziz, VM Corman, AKC Echterhoff, A Richter… - researchgate.net
Background Accurate estimates of SARS-CoV-2 seroprevalence are crucial for the
implementation of effective public health measures, but are currently largely lacking in …

[HTML][HTML] Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

NA Aziz, VM Corman, AKC Echterhoff… - Nature …, 2021 - ncbi.nlm.nih.gov
To estimate the seroprevalence and temporal course of SARS-CoV-2 neutralizing
antibodies, we embedded a multi-tiered seroprevalence survey within an ongoing …

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany.

NA Aziz, VM Corman, AKC Echterhoff, MA Müller… - 2021 - cabidigitallibrary.org
To estimate the seroprevalence and temporal course of SARS-CoV-2 neutralizing
antibodies, we embedded a multi-tiered seroprevalence survey within an ongoing …

[PDF][PDF] Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

NA Aziz, VM Corman, AKC Echterhoff, MA Müller… - scienceopen.com
Number of comorbidities Number of symptoms ELISA- 350 55.1 (12.5) 0.61 1.0 (1.3) 5.2
(4.6) ELISA±/IFT-/PRNT-3 52.3 (11.0) 0.33 2.7 (2.3) 3.3 (3.5) ELISA+/IFT+/PRNT- 2 68.0 …

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany.

NA Aziz, VM Corman, AKC Echterhoff… - Nature …, 2021 - search.ebscohost.com
To estimate the seroprevalence and temporal course of SARS-CoV-2 neutralizing
antibodies, we embedded a multi-tiered seroprevalence survey within an ongoing …

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany

NA Aziz, VM Corman, AKC Echterhoff, A Richter… - 2020 - pesquisa.bvsalud.org
BackgroundAccurate estimates of SARS-CoV-2 seroprevalence are crucial for the
implementation of effective public health measures, but are currently largely lacking in …

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

NA Aziz, VM Corman, AKC Echterhoff… - Nature …, 2021 - ideas.repec.org
To estimate the seroprevalence and temporal course of SARS-CoV-2 neutralizing
antibodies, we embedded a multi-tiered seroprevalence survey within an ongoing …

[PDF][PDF] Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany

NA Aziz, VM Corman, AKC Echterhoff, A Richter… - scholar.archive.org
Background Accurate estimates of SARS-CoV-2 seroprevalence are crucial for the
implementation of effective public health measures, but are currently largely lacking in …